can compete with free hormone for a limited number of antibody-binding sites in a classical competitive immunoassay format. Though conceptually attractive, this approach is technically difficult ...

(A) Competitive immunoassays are comprised of exogenous biotin-conjugated antibodies that compete for binding with an analyte of interest in the patient's sample as well as exogenous labeled analyte.